What tests are used to diagnose Hashimoto's (Hashimoto's thyroiditis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Hashimoto's Thyroiditis

The diagnosis of Hashimoto's thyroiditis requires measurement of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and thyroid autoantibodies—specifically thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TgAb)—with the autoantibodies being the definitive markers that confirm the autoimmune nature of the disease. 1

Initial Laboratory Panel

The cornerstone diagnostic approach involves simultaneous measurement of:

  • TSH and FT4: These should be measured together as the primary assessment of thyroid function 1. TSH is the most reliable indicator of thyroid status, with reference ranges typically 0.4-5.0 mIU/L 2. TSH has sensitivity above 98% and specificity greater than 92% when used to confirm suspected thyroid disease 3.

  • Thyroid Peroxidase Antibodies (TPO-Ab): This is the hallmark autoantibody for Hashimoto's thyroiditis and should be tested in all suspected cases 1. TPO-Ab is present in approximately 80% of Hashimoto's patients 4.

  • Thyroglobulin Antibodies (TgAb): This second autoantibody marker is critical for confirming autoimmune thyroid disease 1. TgAb positivity correlates with symptom burden in Hashimoto's patients, including symptoms like fragile hair, facial edema, eye edema, and harsh voice 5.

Additional Testing Considerations

  • Free T3 (FT3): Consider measuring FT3 when TSH and FT4 results are discordant or when patients remain highly symptomatic despite normal TSH/FT4 values 1.

  • TSH Receptor Antibodies (TRAb): These are not routinely needed for Hashimoto's diagnosis but are essential when differentiating Graves' disease from Hashimoto's thyroiditis in patients presenting with hyperthyroidism 2, 6.

Clinical Context for Testing

Testing should be pursued in patients with:

  • Signs or symptoms suggestive of thyroid dysfunction 3
  • High-risk features: female sex, age >60 years, family history of thyroid disease, personal history of autoimmune disease, type 1 diabetes, previous thyroid dysfunction, or history of head/neck radiation 3
  • Palpable thyroid abnormalities or goiter 3

Important Testing Pitfalls

Avoid these common errors:

  • False TSH elevations: Heterophilic antibodies can cause falsely elevated TSH in some assays 1. Medications like glucocorticoids and dopamine can suppress TSH levels 1.

  • Severe non-thyroid illness: Acute illness can produce false-positive TSH results, with positive predictive values as low as 0.06 for hypothyroidism in hospitalized patients 3.

  • Timing considerations: Multiple TSH measurements over 3-6 months may be needed to confirm persistent abnormalities, as mild TSH elevations often normalize spontaneously 3.

  • Pregnancy effects: Total T4 (TT4) is unreliable during pregnancy due to elevated thyroid-binding globulin; always use FT4 instead 2.

Monitoring After Diagnosis

Once Hashimoto's is confirmed and treatment initiated:

  • Monitor TSH and FT4 every 4-6 weeks initially 1
  • Then every 6-8 weeks during dose titration 1
  • Eventually every 6-12 months once stable 1
  • More frequent monitoring (potentially monthly) is required during pregnancy due to increased thyroid hormone requirements 1

References

Guideline

Laboratory Tests for Hashimoto's Thyroiditis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Thyroid function tests].

Rinsho byori. The Japanese journal of clinical pathology, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.